Get startedLog in
    Picture of Eton Pharmaceuticals logo

    ETON — Eton Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: Eton Pharmaceuticals Announces Acquisition Of FDA-Approved Ultra-Rare Disease Product Nitisinone

    Picture of Eton Pharmaceuticals logoEton Pharmaceuticals
    04/10/2023 11:55
    Oct 4 (Reuters) - Eton Pharmaceuticals Inc  ETON.O :
    * ETON PHARMACEUTICALS ANNOUNCES ACQUISITION OF FDA-APPROVED
ULTRA-RARE DISEASE PRODUCT NITISINONE
    * ETON PHARMACEUTICALS INC - ETON WILL OFFER ETON CARES
SUPPORT
PROGRAM TO ALL PATIENTS
    * ETON PHARMACEUTICALS INC - EXPECT Q1 2024 PRODUCT LAUNCH -
    * ETON PHARMACEUTICALS INC - EXPECT Q1 2024 PRODUCT
NITISINONE
LAUNCH
    * ETON PHARMACEUTICALS INC - TRANSACTION HAS BEEN APPROVED
BY
BANKRUPTCY COURT AND IS EXPECTED TO BE EFFECTIVE ON OCTOBER 12,
2023

Source text for Eikon:  ID:nGNX1Mh749 
Further company coverage:  ETON.O 

 ((Reuters.Briefs@thomsonreuters.com))

    Recent news on Eton Pharmaceuticals

    See all news